Pathophysiology of Post-COVID syndromes: a new perspective

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb, NN Welson - Virology Journal, 2022 - Springer
Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …

Statins use in Alzheimer disease: bane or boon from frantic search and narrative review

N Alsubaie, HM Al-Kuraishy, AI Al-Gareeb, B Alharbi… - Brain Sciences, 2022 - mdpi.com
Alzheimer's disease (AD) was used to describe pre-senile dementia to differentiate it from
senile dementia, which develops in the adult age group of more than 65 years. AD is …

A potential link between visceral obesity and risk of Alzheimer's disease

HM Al-Kuraishy, AI Al-Gareeb, AA Alsayegh… - Neurochemical …, 2023 - Springer
Alzheimer's disease (AD) is the most common type of dementia characterized by the
deposition of amyloid beta (Aβ) plaques and tau-neurofibrillary tangles in the brain. Visceral …

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

[HTML][HTML] COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases

EK Sher, A Ćosović, A Džidić-Krivić, EK Farhat, E Pinjić… - Life sciences, 2023 - Elsevier
SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

Montelukast and acute coronary syndrome: the endowed drug

BM Alomair, HM Al-Kuraishy, AI Al-Gareeb… - Pharmaceuticals, 2022 - mdpi.com
Acute coronary syndrome (ACS) is a set of signs and symptoms caused by a reduction of
coronary blood flow with subsequent myocardial ischemia. ACS is associated with activation …

Post-COVID-19 Pulmonary Fibrosis: Facts—Challenges and Futures: A Narrative Review

S Duong-Quy, T Vo-Pham-Minh, Q Tran-Xuan… - Pulmonary …, 2023 - Springer
Patients with coronavirus disease 2019 (COVID-19) usually suffer from post-acute sequelae
of coronavirus disease 2019 (PASC). Pulmonary fibrosis (PF) has the most significant long …

Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure

HM Al‐kuraishy, AI Al‐Gareeb, A Alexiou… - Journal of …, 2022 - Wiley Online Library
Type 2 diabetes mellitus (T2DM) is a chronic endocrine disorder due to the reduction of
insulin sensitivity and relative deficiency of insulin secretion. Growth differentiation factor 15 …

[HTML][HTML] Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway

WC Chiou, GJ Huang, TY Chang, TL Hsia… - Biomedicine & …, 2023 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection continues to pose
threats to public health. The clinical manifestations of lung pathology in COVID-19 patients …

The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread

AA Alsaidan, HM Al‐Kuraishy… - Immunity …, 2023 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) is a novel pandemic caused by severe
acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). It has been shown that SARS …